proposed endpoints for use in clinical and research studies in the post-MI setting. It is important to highlight that although some pathophysiology and imaging principles apply to both STEMI and non-STEMI, this paper focuses on STEMI.
THE INFARCTED MYOCARDIUM IS NOT STATIC: EVOLVING CHANGES AFTER I/R
A section dedicated to the relevance of animal models to human pathophysiology and how these contribute to our knowledge about I/R can be found in the Online Appendix.
PROGRESSION OF NECROSIS AND ITS
BORDERS. In the late 1970s, Reimer and Jennings (6) (7, 8) .
Despite the prevailing concept based on pathology studies that there is no lateral progression of necrosis, there are some studies suggesting the opposite in some cases (9) (10) (11) . Given that most of these studies used CMR and not pathology, these data should be interpreted with caution.
At the infarct border, histological sections can show apparent isolated islands of surviving myocardium within areas of necrotic tissue, as well as isolated islands of necrosis within areas of viable tissue (12) . In the absence of collaterals, the infarct borders are sharp at a cellular level but may appear to have fuzzy borders when assessed by methods with low resolution relative to cardiomyocyte size due to partial volume errors (13) .
DYNAMIC CHANGES OF INFARCT SIZE AFTER I/R.
When assessing the post-I/R myocardium by CMR, the imaging features of the "infarcted myocardium" can experience important longitudinal changes.
Immediately after reperfusion, the area that will become irreversibly injured increases in size due to reperfusion-related edema. This "swelling" is rapidly reduced, resulting in a decrease in the size of the irreversibly injured myocardium. In the following days, dead cardiomyocytes and debris are progressively removed from the post-I/R region, while there is an intense transit of inflammatory cells and a
HIGHLIGHTS
CMR is increasingly used for improved long-term risk stratification of post-MI patients and to initially evaluate cardioprotective interventions.
There is a need to standardize CMR endpoints, which should rely on pathophysiology and association with hard endpoints.
This document presents a consensus of recommendations of CMR endpoints selection in experimental and clinical trials.
Universal standardization of CMR protocols/endpoints will accelerate the process of bringing cardioprotective interventions into clinical practice.
Future studies should serve to introduce CMR as an indispensable tool affecting decision-making in daily practice. progressive deposition of collagen. These changes result in a further "shrinkage" of the infarcted region ( Figure 1) . Depending on the extent of irreversible injury and its spatial distribution (e.g., subendocardial, transmural, or patchy), these changes can be of different magnitudes. This concept is important, because the imaging biomarker "infarct size" (as % of LV) can vary greatly at different time points after MI (14) (15) (16) . Studies aiming to quantify MI size should be consistent in the choice of the imaging time point to reduce variability and bias in outcome measure.
PATHOPHYSIOLOGY AND SPATIAL DISTRIBUTION
OF POST-I/R EDEMA. In the healthy heart, myocardial water content is mostly intracellular, with a very small interstitial component (17) . Upon MI, myocardial edema occurs initially as cardiomyocyte swelling Small animal models (mice, rats) are useful for specific mechanistic evaluations but do not resemble human pathophysiology. It is not recommended to translate results from these models into humans without first testing in large animals (126) .
Pig and dog I/R models have similarities and differences with humans but are the closest to human pathophysiology and may be considered complimentary* (primates are not considered for ethical reasons) (126) .
The post-I/R region (infarcted and salvaged) is not static and exhibits important temporal changes in size and composition (14) .
There is greater edema formation in infarcted tissue than in salvaged myocardium (22, 70) .
After acute MI, the infarct border can be highly irregular with islands and peninsulas of necrosis but with a sharp boundary and no "intermediate zone" at a cellular level (12) . "Fuzzy borders" at the edge an acute infarct can arise from partial volume effect due to limited spatial resolution of imaging (13) .
In experimental models, edema after I/R is bimodal (70, 80, 127) . There is an initial reperfusion-related wave of edema that significantly attenuates hours after reperfusion. A second healing-related wave of edema initiates days after reperfusion and lasts longer (15, 50) .
In humans, the dynamics of post-I/R edema is less well established. At least in some patients it might exhibit a 2-wave pattern (45, (81) (82) (83) . Edema appears to be more stable in the time window between days 3 and 7 post-MI (15, 45, 82, 83, 90) .
MVO precedes IMH in reperfused infarctions (15, 128) .
*Controversial topic (majority but not all panelists in agreement).
IMH ¼ intramyocardial hemorrhage; I/R ¼ ischemia/reperfusion; MI ¼ myocardial infarction; MVO ¼ microvascular obstruction. (17) .
In relation to the spatial extent of post-MI edema, classic pathology studies have demonstrated larger amounts of edema in the actual infarcted myocardium than in the "reversible" injured tissue (i.e., salvaged myocardium) (18, 22) . These classical studies showed that infarcted myocardium has an increase in water content of #90%, while salvaged myocardium only has an increase of water content of #9% for <24 h. As discussed in more detail in subsequent sections, the dynamics of post-MI edema is highly complex. LGE in the acute phase. The hyperenhancement in the acute phase is partially due to the edema-related increase in the size of the infarcted portion, occupying a large part of the voxel. In the chronic phase, LGE can disappear. This is partially due to the shrinkage of the patchy dead myocardium, with neighbor alive cardiomyocytes occupying a large part of the voxel. CMR ¼ cardiac magnetic resonance.
been shown to occur in large animal models and in humans (24) (25) (26) . These chronic iron deposits have been associated with significant prolonged proinflammatory burden, poor LV remodeling, and major adverse cardiovascular events. Thus, markers of severe forms of tissue injury, particularly MVO and IMH, appear to be key targets for post-infarction therapy (27) . See Table 1 for consensus related to I/R concepts and animal models.
POST-MYOCARDIAL INFARCTION TISSUE CHARACTERIZATION BY CMR
The aim of this section is to provide an overview of other abbreviations as in Figure 2 .
myocardium. But, at a later time point, shrinkage of these peninsulas or islands leads to a changed partial volume effect, and voxels at the infarct border may no longer be considered hyperenhanced since they are now below the cutoff threshold (31) (Figure 3 ).
For certain types of injuries, the combination of infarct shrinkage and partial volume effect can lead to
LGE findings that are particularly prone to misinterpretation. If there is patchy necrosis, hyperenhancement in the acute setting may resolve and be absent in the chronic setting ( Figure 2 ). Pre-and post-contrast T1 mapping for assessment of acute infarct size. ECV mapping is determined by obtaining repeated T1 maps before (native T1 map) and again after contrast media administration (3).
ECV agrees well with final infarct size revealed by
LGE (32) . Despite the fact that native T1 and ECV mapping might overcome some of the limitations of
LGE imaging, it is subjected to the same considerations regarding infarct size dynamics. In addition, the spatial resolution of ECV mapping is inherently less than that of LGE imaging.
A section dedicated to post-processing of LGE and edema images is presented in the Online Appendix. values in milliseconds on a fixed scale, subjective signal intensity-based ascertainment is avoided.
T2 mapping has been validated against pathology for myocardial water content quantification in experimental MI models (35, 56) . A comparative study using repeatedly 4 different edema sequences showed higher intraobserver and interobserver agreement and greater test-retest reproducibility in the quantification of edema using T2 mapping (57). In the left case, the entire AAR is transmurally infarcted with no salvage at all. In the case to the right, AAR is much larger, but infarction occupies only the subendocardial area, suggesting large amount of salvaged myocardium. The case to the right corresponds to a subject undergoing a given cardioprotective strategy (IPC in this case). Abbreviations as in Figure 2 . However, other studies are questioning its accuracy in STEMI patients with minimal or no LGE (11, 67, 68) .
D y n a m i c s o f p o s t -M I e d e m a : t h e c l a s s i c c o n c e p t o f " s t a b l e " m y o c a r d i a l e d e m a t o u s r e a c t i o n r e v i s i t e d . Post-MI edema was initially believed to be stable during the days following an acute MI (14,66).
Recent studies have provided new insights. In the experimental setting, it has been demonstrated that the edematous reaction during the first week after MI is not stable, and follows a bimodal pattern (79, 80) . In summary, there is robust evidence for the bimodal edema pattern at the experimental level. In patients, some (not all) studies have also demonstrated a bimodal edema reaction within the first week of MI.
E f f e c t o f p r o t e c t i v e t h e r a p i e s o n e d e m a :
implications for edema-based AAR quantification. Conceptually, the AAR is the myocardium downstream to an occluded coronary artery that becomes ischemic (1) .
Infarct size and AAR should be ideally measured at the same time point. If measured at different time points, salvage quantification might show implausible results (e.g., negative values) (14) (15) (16) 90 ).
LGE grey zones should not be interpreted as dead, since they likely represent a mixture of bright (dead) and dark (alive) myocardium. Grey myocardium can be due to partial volume effect (15, 31) .
Edema development should be interpreted as a manifestation of myocardial I/R injury and should not be considered as a reliable marker of AAR* (15, 44, 89) .
T1W is the recommended methodology for LGE imaging after MI (2,4).
T2-mapping is the recommended methodology for edema imaging after MI (3, 35) .
T1W
LGE is the recommended methodology for MVO imaging (hypointense areas within the LGE area) (95) . T2* mapping is the recommended methodology for IMH imaging after MI (3).
AAR ¼ area at risk; LGE ¼ late gadolinium enhancement; other abbreviations as in Table 1 .
Ibanez et al. It is recommended that the index CMR scan be performed 5 AE 2 days after reperfusion. At this time point, several key parameters have been shown to be relatively stable.
LGE extent, expressed both in absolute (grams) and relative (percentage of LV mass) terms, is the recommended CMR primary endpoint (106, 107) .
In experimental studies, if LGE extent is expressed as a ratio to AAR, the latter should not rely on edema and ideally both AAR and LGE have to be obtained at the same day post-MI (e.g., perfusion imaging during coronary occlusion by MDCT) and LGE by CMR) (15, 89, 90) .
LVEF (%) and MVO (areas of hypoenhancement within LGE, in grams or as % of LV) are recommended as main secondary endpoints (105, 108) .
Edema extent (T2 mapping) may be used as secondary endpoint to assess the effect of cardioprotective therapies (89) .
LV volumes (ml; ml/m 2 ), RVEF (%), RV LGE (presence), and IMH (% of LV) can be included as secondary endpoints (111) (112) (113) (114) .
Myocardial mapping indexes (T1 [ms]; T2 [ms]; ECV [percentage of LV mass])
, and strain (feature tracking) may be considered as exploratory endpoints (15, 65, 88, (117) (118) (119) .
The use of edema-sensitive CMR sequences as a surrogate for AAR (as well as edema-based MSI) is not recommended because edema is not stable in the days following MI, and is potentially affected by duration of ischemia, and by cardioprotective strategies* (15, 45, 89) .
Due to its easy implementation, ESL-based salvage index may be used as an exploratory outcome but not in cases with small amounts of LGE or aborted infarction, i.e., when a high degree of cardioprotection is expected* (11, 67, 68, 77, 78) .
For LGE post-processing, automated techniques using signal-intensity thresholding, manual delineation, and visual scoring (the 2 latter at intermediate signal-intensities) have similar good accuracy and reproducibility (129). For delineation of edema, T2 mapping (automated >2SD thresholding with manual correction) showed greater intraobserver and interobserver agreement (57) . For MVO quantification, the most widely used is the manual delineation of dark areas within LGE region. Extended information is provided in the Online Appendix. *Controversial topic (majority but not all panelists in agreement).
AAR ¼ area at risk; ECV ¼ extracellular volume; ESL ¼ endocardial surface length; LVEF ¼ left ventricular ejection fraction; MSI ¼ myocardial salvage index; RV ¼ right ventricle/ventricular; other abbreviations as in Table 1 .
edema in the acute phase. Because T1 is sensitive to the degradation products of hemorrhage, some studies have also investigated the capacity to image hemorrhage with T1 CMR. These studies have shown that the opposite effects hemorrhage and edema impose of T1, the sensitivity for detecting hemorrhage based on T1 after MI is often compromised (99) .
See Table 2 for consensus related to CMR methodologies for tissue characterization.
CMR ENDPOINTS IN CLINICAL TRIALS AND EXPERIMENTAL STUDIES
Large animal experimentation is necessary before 
CMR in STEMI Trials

